Wuliangye (000858): Nomura starts Wuliangye at Neutral as channel destocking progresses but demand recovery remains gradual
Nomura sees Wuliangye retaining strong premium-baijiu positioning and expects core-product volume and pricing to recover as inventories normalize. It initiates coverage at Neutral with a CNY73.59 target price, implying 6.8% upside.
Summary
Nomura sees Wuliangye retaining strong premium-baijiu positioning and expects core-product volume and pricing to recover as inventories normalize. It initiates coverage at Neutral with a CNY73.59 target price, implying 6.8% upside.
- Wuliangye held a 12.4% share of China’s ultra-premium baijiu market in 2025, ranking second.
- Regulated commodities were CNY4.51bn at end-June 2026, down 11.4% year-on-year and 8.2% from end-2025.
- Nomura forecasts revenue of CNY51.86bn, CNY53.88bn and CNY55.98bn for 2026-28F.
- The target price is based on 18x 2026F P/E and 2026F EPS of CNY4.09.
- Key risks are continuing wholesale-price pressure and tighter restrictions on business and government-related consumption.
Report Interpretation
Overview
This initiation report examines whether Wuliangye’s leading position in premium baijiu can translate into a sustained recovery while end-demand remains soft. Nomura expects destocking and core-product recovery to support earnings normalization, but maintains a Neutral rating because pricing and demand conditions remain uncertain.
Core views
Nomura argues that Wuliangye remains a leading premium-baijiu producer despite soft end-demand and an ongoing channel adjustment. Euromonitor data place its 2025 ultra-premium-market share at 12.4%, second in the market and 2.5 percentage points ahead of Jiannanchun. Although Wuliangye’s share fell 1.1 percentage points year-on-year and its gap with Moutai widened to 20.6 percentage points, Nomura considers its brand recognition and channel strength in the CNY1,000 price band durable. Market concentration increased, with the top-three share rising from 52.5% in 2021 to 55.3% in 2025, but intensified competition and weak industry demand mean a sustained recovery in volume and pricing still needs confirmation. The near-term operating picture is mixed. Reported 1H26 revenue rose 20.9% year-on-year to CNY28.42bn and net profit rose 89.3% to CNY8.75bn, but 2Q26 revenue declined 13.2% to CNY5.58bn, which Nomura views as evidence of persistently weak end-demand. The strong 1H26 profit growth reflected a more favorable product mix and a lower taxes-and-surcharges ratio. Wuliangye-branded baijiu revenue increased 72.8% to CNY23.63bn, supported by quota phasing around the Chinese New Year peak season and emerging-channel expansion; volume rose 88.3% to 16kt while ASP fell 8.2% to CNY1.451m per tonne. This product line represented 83.2% of revenue, up 25.0 percentage points year-on-year, and helped lift blended gross margin 2.4 percentage points to 80.3%. In contrast, other-liquor revenue fell 60.2% to CNY3.23bn and volume fell 63.8%, reflecting pressure in mid-range products amid competing premium-baijiu price cuts. Channel inventory is the main recovery mechanism in Nomura’s thesis. Regulated commodities were CNY4.51bn as of 30 June 2026, down 11.4% year-on-year and 8.2% from end-2025, which the institution interprets as progress in destocking. It expects the ASP of 8th-Generation Wuliangye to decline 2.8% in 2026F, partly because of product mix and possible pricing flexibility to facilitate channel adjustment. Once inventories normalize and supply-demand conditions improve, Nomura forecasts ASP growth of 1.6% in 2027F and 1.3% in 2028F. It forecasts Wuliangye-branded product volume growth of 66.9% in 2026F, slowing to 2.0% and 2.3% in 2027F and 2028F on a higher base and a gradual underlying-demand recovery. The core business is projected to account for 87.4%, 87.2% and 87.0% of revenue in 2026-28F, with gross margin broadly stable at 85.9%, 86.0% and 86.0%. Nomura expects other-liquor products to remain under pressure in 2026F: volume is forecast to decline 65%, while gross margin is assumed to stay at 60.0% through 2028F because competition in mid- and lower-price segments remains intense. It expects revenue contribution from this segment to be 6.7%-7.0% during 2026-28F. Non-liquor products are forecast to decline 10% in 2026F before growing 5% in each of 2027F and 2028F. Expense assumptions remain conservative: the selling-expense ratio rose 7.4 percentage points to 22.2% in 1H26 because of market investment, and Nomura forecasts 23%, 22% and 21% for 2026-28F as consumer-engagement and retail-channel spending stays elevated. It assumes taxes and surcharges normalize at about 15%, after falling from 27.2% in 2025 to 14.8% in 1H26. On this basis, Nomura forecasts revenue of CNY51.86bn, CNY53.88bn and CNY55.98bn and net profit of CNY15.87bn, CNY16.45bn and CNY17.39bn in 2026-28F. Its revenue forecasts are 10.6%, 5.5% and 1.0% above Wind consensus, reflecting a faster assumed recovery in core-product volumes. Its 2026F net-profit estimate is 5.4% above consensus, but its 2027F and 2028F estimates are 2.1% and 6.8% below consensus because it assumes higher selling expenses amid sustained competition. Nomura values Wuliangye using 18x 2026F P/E, above the peer average of 16.3x, to reflect its leading premium-baijiu channel position. Applying the multiple to 2026F EPS of CNY4.09 produces a CNY73.59 target price, 6.8% above the CNY68.91 closing price on 28 September 2026. The stock traded at 16.9x 2026F P/E. Nomura initiates coverage at Neutral, consistent with its view that earnings should recover and stabilize but that end-demand, wholesale pricing and channel normalization remain key uncertainties. Potential catalysts are progress on the CNY8bn-CNY10bn share-repurchase plan and further channel destocking.
Analysis framework
Nomura assesses Wuliangye’s market position, channel inventory, product-level volume, ASP and margin trends, then builds 2026-28F segment forecasts and expense assumptions. It compares its earnings estimates with Wind consensus and derives the target price by applying a peer-informed P/E multiple to its 2026F EPS forecast.
Methodology notes
Product-level volume, ASP and gross-margin analysis
The report separates revenue recovery into volume and pricing effects for Wuliangye-branded and other-liquor products, linking both to channel inventory and industry demand.
Forward P/E multiple valuation
Nomura applies 18x 2026F P/E to forecast EPS of CNY4.09, comparing the selected multiple with a 16.3x peer average to derive the target price.
Channel inventory and supply-demand normalization
The report uses declining regulated commodities as evidence of destocking and expects healthier inventories and supply-demand conditions to support later ASP and volume recovery.
Asset mapping & comparison
Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).
- Wuliangye (000858.SZ)Primary covered company; its premium-baijiu leadership and channel destocking underpin the recovery thesis.
- Strengths
- Second-ranked 12.4% ultra-premium market share in 2025, strong brand recognition and channel strength in the CNY1,000 price band.
- Weaknesses
- Soft end-demand, a 13.2% year-on-year 2Q26 revenue decline, and near-term ASP pressure.
- Comparison
- Nomura applies 18x 2026F P/E versus a 16.3x average for Kweichow Moutai, Luzhou Laojiao and Anhui Gujing Distillery.
- Risks
- Sustained wholesale-price pressure could weaken distributor incentives and sell-through; tighter consumption regulations could depress premium-baijiu demand.
- Kweichow Moutai (600519 CH)Valuation comparable.
- Comparison
- Included in Nomura's peer set and rated Buy.
- Luzhou Laojiao (000568 CH)Valuation comparable.
- Comparison
- Included in Nomura's peer set and rated Buy.
- Anhui Gujing Distillery (000596 CH)Valuation comparable.
- Comparison
- Included in Nomura's peer set and marked Not Rated.
Key data
- Ultra-premium baijiu market share12.4% in 2025Wuliangye ranked second; 2.5 percentage points ahead of Jiannanchun.
- Regulated commoditiesCNY4.51bn as of 30 June 2026Down 11.4% year-on-year and 8.2% from end-2025.
- 1H26 revenue and net profitCNY28.42bn and CNY8.75bnUp 20.9% and 89.3% year-on-year, respectively.
- 2Q26 revenueCNY5.58bnDown 13.2% year-on-year.
- 2026-28F revenueCNY51.86bn / CNY53.88bn / CNY55.98bnNomura forecasts.
- 2026-28F net profitCNY15.87bn / CNY16.45bn / CNY17.39bnNomura forecasts.
- Target priceCNY73.59Derived from 18x 2026F P/E on EPS of CNY4.09; implies 6.8% upside.
Impact & implications
Nomura expects Wuliangye’s core-product recovery, channel destocking and later ASP normalization to support a rebound in earnings. However, it believes that weak end-demand, wholesale-price pressure and elevated selling investment justify a Neutral stance rather than a more positive rating.
Risks
- Continued pressure on the wholesale price of 8th-Generation Wuliangye could squeeze distributor margins, weaken distributor incentives and weigh on end-market sell-through.
- Further tightening of regulations on business and government-related consumption could keep premium-baijiu demand under pressure.
What to watch
- Progress on the CNY8bn-CNY10bn share-repurchase plan.
- Further channel destocking and the trajectory of regulated commodities.
- Whether the wholesale price of 8th-Generation Wuliangye stabilizes and recovers.
- The pace of macroeconomic recovery, business activity and premium-banquet demand.